Skip to main content
SpringerLink
Log in

Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys

  • Research Highlight
  • Published:
Neuropsychopharmacology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Woodlief K, Allen MI, Cornelissen JC, Banks ML, Newman AH, Nader MA Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Neuropsychopharmacology. 2023:1–8. In press.

  2. Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N. Engl J Med. 2017;377:391–4.

    Article  PubMed  Google Scholar 

  3. Kumar V, Bonifazi A, Ellenberger MP, Keck TM, Pommier E, Rais R, et al. Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment. J Med Chem. 2016;59:7634–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Khemiri L, Steensland P, Guterstam J, de Manzano Ö, Franck J, Jayaram-Lindström N. Effects of the monoamine stabilizer (-) OSU6162 on cognitive function in alcohol dependence. Psychopharmacology 2020;237:69–82.

    Article  CAS  PubMed  Google Scholar 

  5. Khemiri L, Steensland P, Guterstam J, Beck O, Carlsson A, Franck J, et al. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: a human laboratory study. Eur Neuropsychopharmacol. 2015;25(Dec):2240–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Funding

The effort spent writing this article was supported by UH3DA047711 (Principal Investigator: SDC).

Author information

Authors and Affiliations

  1. Division on Substance Use Disorders, New York State Psychiatric Institute, New York, NY, USA

    Samantha Chong & Sandra D. Comer

  2. Columbia University Irving Medical Center Department of Psychiatry, New York, NY, USA

    Sandra D. Comer

Authors
  1. Samantha Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra D. Comer
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SC wrote the first draft of the article and SDC helped with revisions of it. Concept and design: SDC. Acquisition, analysis, or interpretation of data: Not applicable. Drafting of manuscript: SC, SDC. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Not applicable. Administrative, technical, or material support: Not applicable. Supervision: SDC.

Corresponding author

Correspondence to Sandra D. Comer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chong, S., Comer, S.D. Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Neuropsychopharmacol. 48, 1703–1704 (2023). https://doi.org/10.1038/s41386-023-01726-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41386-023-01726-w

  • Springer Nature Switzerland AG

Search

Navigation